For Investors

Apillet is a Drug Delivery Company where the core business strategy is to partner its proprietary oral drug delivery technology. Our partners can leverage our expertise to employ our unique gastro-resistant enteric encapsulation mechanism to advance their portfolio.

The application of new specialized coatings in pharmaceuticals will represent a valuable possibility for the development of new tablets and capsules for oral delivery of Biopharmaceuticals, Sensitive pharmaceuticals, Prebiotics/Probiotics and Nutraceuticals. 

The funding needed to secure patents on national levels has been secured with early investors. However, we are now in the process of onboarding new investors to bring this promising project fast towards the market.  

for a more thorough presentation of the asset and the investment opportunity